Want quality care? Keep physicians informed
Imagine seeing a patient who was once dependent upon a cane begin to move about unassisted.
Indiana Gov. signs law on biosimilar substitution
Indiana Governor Mike Pence this week signed Senate Bill 262, a bill on biosimilar drugs that allows substitution if certain conditions are met.
European survey highlights gaps in knowledge of biosimilars
The Alliance for Safe Biologics and EuropaBio recently released results of a survey of 470 European physicians’ views on biosimilar naming.
Biologic Therapy Substitution to be Considered by World Health Assembly
Recently two World Health Organization resolutions were approved for consideration at the 67th World Health Assembly, to convene this coming May in Geneva.
New IfPA Paper: Why Doctors Need to Know When Pharmacists Substitute Biological Medicines
Today the Institute for Patient Access released a new policy brief entitled “WHY DOCTORS NEED TO KNOW WHEN PHARMACISTS SUBSTITUTE BIOLOGICAL MEDICINES.”
Cancer Patients Want More Information on Rx Switches
In some cases, patients switch between using similar medications without thinking twice. Aspirin and ibuprofen, for example, are both over-the-counter medications for treating minor pain. But not every swap is as easy to understand.
